On ECHEMI
Home > Drugs > Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
  • Founded in:

    2000-07-17
  • Country:

    China China
  • Address:

    No. 1588, Xinming Road, Economic Development Zone, Pinghu City, Zhejiang Province
  • Tax NO.:

    91330000146644116H
  • Registered Funds:

    375.925005 yuan
  • Website:

  • Email:

Related Drugs
Acetaminophen suppositories
Each tablet of this product contains 0.15g of acetaminophen. Excipients: Tween-80, mixed fatty acid glycerides.
Name Description Content CAS NO. Registered Holders
Acetaminophen

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

0.15g 103-90-2 68
Tween 80

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

9005-65-6 17
Mixed fatty acid glyceride

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

0
Acetaminophen suppositories
Each tablet of this product contains 0.15g of acetaminophen. Excipients: Tween-80, mixed fatty acid glycerides.
Name Description Content CAS NO. Registered Holders
Acetaminophen

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

0.15g 103-90-2 68
Tween 80

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

9005-65-6 17
Mixed fatty acid glyceride

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

More

This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects.

0
Metronidazole Sodium Chloride Injection
The main ingredient of this product is: metronidazole.
Name Description Content CAS NO. Registered Holders
Metronidazole

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. Actinomycetes, Lactobacillus and Propionibacterium are resistant to it. It can also inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. It has a strong effect of killing trichomonas, and its mechanism is unknown. It is carcinogenic to some animals.

More

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. Actinomycetes, Lactobacillus and Propionibacterium are resistant to it. It can also inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. It has a strong effect of killing trichomonas, and its mechanism is unknown. It is carcinogenic to some animals.

443-48-1 39
Ciprofloxacin Lactate Sodium Chloride Injection
The main ingredients of this product are: Ciprofloxacin lactate Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid lactate Molecular formula: C17H18FN3O3C3H6O3 Molecular weight: 421.43
Name Description Content CAS NO. Registered Holders
Ciprofloxacin lactate

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli, and Moraxella. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli, and Moraxella. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Ciprofloxacin Lactate Sodium Chloride Injection
The main ingredients of this product are: Ciprofloxacin lactate Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid lactate Molecular formula: C17H18FN3O3C3H6O3 Molecular weight: 421.43
Name Description Content CAS NO. Registered Holders
Ciprofloxacin lactate

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against most bacteria of the Enterobacteriaceae family (including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacteriaceae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc.). It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. It has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against most bacteria of the Enterobacteriaceae family (including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacteriaceae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc.). It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. It has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.